Santos da Silva Jorge 4

What Happened
Santos da Silva Jorge, CEO of MoonLake Immunotherapeutics (MLTX), sold 47,775 shares on July 1, 2026 for a total of approximately $956,933. The reported weighted average sale price was $20.03 per share; individual sales ranged from $20.00 to $20.09. The transaction is coded as a sale (S) — sales are often routine and do not necessarily indicate a change in the insider’s view of the company.

Key Details

• Transaction date: July 1, 2026; Form 4 filed July 2, 2026 (filed one day after the trade).
• Shares sold: 47,775; weighted average price: $20.03; total proceeds ≈ $956,933.
• Price range reported: $20.00 to $20.09 across multiple trades.
• Shares owned after the transaction: not specified in the provided filing summary.
• Footnotes:
  • F1: Sale executed under a Rule 10b5‑1 trading plan adopted March 31, 2026.
  • F2: Weighted average price shown; the filing notes multiple sale prices and states that, upon SEC staff request, the filer will provide a breakdown of shares sold at each price.

Context
This was an open‑market sale executed under a prearranged 10b5‑1 plan, which allows insiders to sell at scheduled times and can reduce the likelihood that the sale was based on nonpublic information. For retail investors, purchases generally carry more direct signals about insider sentiment than routine sales; this filing documents disposition of shares but does not, on its own, indicate material new information about MoonLake’s prospects.